Metabolic Profile and Anthropometric Changes in Schizophrenia

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

"No clinical differences will be found between the three antipsychotics under study - olanzapine, risperidone and haloperidol - on the patients' metabolic profile and weight. "

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Central Institute of Psychiatry, Ranchi, India
• Treatments: Haloperidol; Haloperidol decanoate; Olanzapine; Risperidone

Criteria

Inclusion Criteria:

• Age between 18-40 years

• Diagnosis of schizophrenia

• Drug naive on admission

Exclusion Criteria:

• Other psychiatric co-morbidity

• History of severe physical illness

• Alcohol and substance abuse or dependence

• History of pre-existing diabetes or hypertension

• Family history of hypertension or diabetes